{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Arbutus Biopharma Corporation"},"Symbol":{"label":"Symbol","value":"ABUS"},"Address":{"label":"Address","value":"701 VETERANS CIRCLE, WARMINSTER, Pennsylvania, 18974, United States"},"Phone":{"label":"Phone","value":"+1 267 469-0914"},"Industry":{"label":"Industry","value":"Pharmaceuticals and Biotechnology"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology."},"CompanyUrl":{"label":"Company Url","value":"http://www.arbutusbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Michael J. Sofia","title":"Chief Scientific Officer"},{"name":"William H. Collier","title":"President, Chief Executive Officer &amp; Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}